CClinicalTrials.gg
Status unknownNCT00664235Updated Apr 22, 2008

The Analysis of Skin Temperature by Long Wave Infrared Imaging to Determine Its Effectiveness as a Predictor of Tissue Injury

An observational study in Pressure Ulcers and Tissue Injury, sponsored by Trillennium Medical Imaging, Inc.. Status unknown at 1 site in United States. Per ClinicalTrials.gov, last updated 2008-04-22.

Sponsored by Trillennium Medical Imaging, Inc. · Observational

The sponsor has not verified this record recently (last verified Apr 2008), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Time perspective
Prospective
Enrollment
100
Sex
All
01

Study summary

Long-wave infrared imaging can be used to identify skin temperature changes associated with underlying tissue changes. We want to determine if the use of Long Wave infrared Imaging is as effective as the Braden Score in predicting nosocomial pressure ulcers.

Read the detailed description

The Trillennium Medical Imaging system will be used to gather skin temperature data on 100 subjects. The subjects will be enrolled from Duke North floors 8100 or 8300 in a prospective controlled trial. All eligible patients who have signed a consent form will be assessed using the Long Wave Infrared imaging.

Subjects eligible for this study who have signed a consent form will be scanned on bilateral heels and sacrum. Subjects with ulcers on those areas will also be scanned due to the fact that they are at a high risk of developing additional pressure ulcers. The intent is not to capture images of the existing ulcer, but to focus on areas that could potentially develop into additional pressure ulcers. The subjects who already have an ulcer will only be scanned on non ulcerated tissue. The areas of interest must be off-loaded for 3 minutes from any pressure in order to acclimate to ambient temperature. The device will be held approximately 36 inches from the area of interest in order to obtain an image. The subjects will be assessed within 24 hours of admission and every 24 hours until discharge or they develop a pressure ulcer. The subject's routinely recorded Braden scores (By on the floor nursing staff) will also be captured in order to effectively compare the effectiveness of the Imaging system. The nurse conducting the imaging will also record a Braden score.

All subjects will be included in the trial unless they refuse to participate or are incapacitated to the degree that imaging becomes unreasonable.

02

Conditions studied

  • Pressure Ulcers
  • Tissue Injury

Keywords

  • Pressure Ulcers
  • Tissue Injury
03

In context

Pressure Ulcer

518 studies on the registry are indexed under Pressure Ulcer; 117 are open to participants now.

This study's planned enrollment of 100 is below the median of 154 across 97 observational studies indexed under Pressure Ulcer.

Browse Pressure Ulcer studies →

Lead sponsor

This is the only study on the registry with Trillennium Medical Imaging, Inc. as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients will be recruited from Duke North inpatient unit 8100 or 8300. All patients admitted to the above floor will be evaluated for willingness to participate.

Inclusion criteria

  • To be admitted to 8100 or 8300 and be willing to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Unwillingness to participate
05

Study design

Time perspective
Prospective
Enrollment
100 participants (estimated)
06

What researchers measure

Primary outcomes

  1. Each time a pattern of injury is identified by the device, we will correlate this occurrence with the Braden scale to see whether or not it suggested an injury potential.

    Time frame: 90 days

Secondary outcomes

  1. It is our hypothesis that the pattern of injury will develop without warning from the Braden scores.

    Time frame: 90 days

07

Study locations

1 of 1 sites recruiting
  • Duke University Health System
    Durham, North Carolina 27710, United States
    • David W. Judy, D.O. · Contact · david.judy@duke.edu · 919-668-0145
    • Claude S. Burton, M.D. · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 22, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00664235
Lead sponsor
Trillennium Medical Imaging, Inc.
First posted
Apr 22, 2008
Start date
Feb 2008
Primary completion
Apr 2008 (estimated)
Completion
Jun 2008 (estimated)
Last update
Apr 22, 2008

Study contacts

David W Judy, D.O.
Contact
david.judy@duke.edu
919-668-0145
Edna E Atwater
Contact
atwat004@mc.duke.edu
919-684-5381
Claude S. Burton, M.D.
principal investigator · Duke Health

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion